Cyclophosphamide, adriamycin and cis-platinum in treatment of ovarian common epithelial cancer stage III-IV.

Twelve patients with ovarian common epithelial cancer stage III, IV were treated by post operative chemotherapy; combination of cyclophosphamide, adriamycin and cis-diamminedichloroplatinum. Their revealed overall response rate was 83.3%, clinical complete remission was 66.6%, with a follow-up period of 10.0-23.5 months, and was negative on second look operation 83.3%. The response rate was 77.7%, for residual cancer > 5.0 cm. with a clinical complete remission 55.5%, and was negative on second look operation 66.6%.